Role of brain natriuretic peptide in the pathogenesis of resistant hypertension

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension

Modern medicine has successfully used the N-terminal pro-brain natriuretic peptide (NT-proBNP) as a biomarker for many cardiovascular diseases (CVDs). According to a number of studies, NT-proBNP may also play a role in the development of resistant hypertension (RH), but the existing work addresses t...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. Yu. Nikolaev, A. V. Shilova, A. Ya. Kovaleva, G. I. Lifshits
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2023-02-01
Series:	Российский кардиологический журнал
Subjects:	resistant hypertension natriuretic peptide bnp antihypertensive therapy
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5188
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Parallels of structural-functional parameters the myocardium, C-type natriuretic peptide and endothelin-1 plasma concentrations in women with uncomplicated essential hypertension
by: V. V. Petrovska, et al.
Published: (2014-12-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

Effect of iPS cell culture medium on the differentiation potential of induced cardiac tissues
by: Yoshiki Nakashima, et al.
Published: (2025-08-01)

Serum N‐Terminal Pro‐B‐Type Natriuretic Peptide Is Associated With Insulin Resistance in Chinese: Danyang Study
by: Ziwen Zheng, et al.
Published: (2024-11-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Action on elevated natriuretic peptide in primary care: a retrospective cohort study
by: Cornelia JC Vermeer, et al.
Published: (2025-04-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01)

Increased natriuretic peptides not associated with heart failure
by: A. M. Chaulin, et al.
Published: (2021-01-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
by: Paulo Bettencourt PhD, et al.
Published: (2021-06-01)

Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation
by: Giorgia Manni, et al.
Published: (2025-07-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct
by: Evgenij G. Furman, et al.
Published: (2019-04-01)

Evaluation of proinflammatory cytokines and brain natriuretic peptide in patients with rheumatic heart diseases and coronary heart disease complicated by chronic heart insufficiency
by: N A Shoslak, et al.
Published: (2005-04-01)

Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age
by: Zhen-qing Liu, et al.
Published: (2025-07-01)

An applied study of B-type natriuretic peptide in a non-dialysis population with chronic kidney disease
by: WANG Xiao-yu, et al.
Published: (2020-01-01)

Hyponatremia and brain injury: absence of alterations of serum brain natriuretic peptide and vasopressin Hiponatremia e traumatismo cranioencefálico: ausência de alteração sanguínea do peptídeo natriurético cerebral e hormônio antidiurético
by: Karina Nascimento Costa, et al.
Published: (2009-12-01)

TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION
by: Y. A. Vasyuk, et al.
Published: (2016-01-01)

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
by: T. A. Panafidina, et al.
Published: (2017-09-01)

Analysis of peripheral blood variables in evaluation and prediction of adverse outcomes with hypertensive disorders of pregnancy
by: Yingdi Jiang, et al.
Published: (2025-08-01)

Atrial Natriuretic Peptide at Discharge as a Predictive Marker for Early Rehospitalization in Patients With Heart Failure With Preserved Ejection Fraction
by: Junichi Ohno, et al.
Published: (2025-08-01)

Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology
by: Yu. A. Andreeva, et al.
Published: (2010-04-01)

Bioactive Peptides Derived from Tuna: Screening, Extraction, Bioactivity, and Mechanism of Action
by: Jing-an Cheng, et al.
Published: (2025-07-01)

Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure: a prospective cohort study in Vietnam
by: Chau Minh Truong, et al.
Published: (2025-07-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

Content of Some Endothelium-Dependent Vasoactive Substances of Blood Plasma, Indicators of Renin-Aldosterone System, Natriuretic Hormone in Patients with Decompensated Liver Cirrhosis and their Dependence on the Severity Grade of Portal Hypertension
by: Ferko M.
Published: (2015-12-01)

N-TERMINAL PROHORMONE OF BRAIN NATRIURETIC PEPTIDE IN THE DIAGNOSIS AND MANAGEMENT OF PERSISTENT PULMONARY HYPERTENSION IN NEWBORNS
by: Sinan Tüfekci, et al.
Published: (2022-03-01)

Hypertension
by: J.A. Ker
Published: (2011-07-01)

Combining clinical markers can predict mortality in NYHA IV heart failure
by: Yi-jiao Men, et al.
Published: (2025-08-01)

ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES?
by: T. A. Kazakovtseva, et al.
Published: (2016-01-01)

Clinical value of BNP and NT-proBNP for evaluating the cardiac function of patients with chronic renal failure
by: TANG Li, et al.
Published: (2016-01-01)

Risk factors of severe heart failure in HIV-positive patients
by: O. G. Goryacheva, et al.
Published: (2021-02-01)

Pulmonary hypertension and NT-proBNP dynamics during the course of adulticide treatment in dogs naturally infected by Dirofilaria immitis
by: Noelia Costa-Rodríguez, et al.
Published: (2025-07-01)

STEPWISE management of clinically apparent resistant hypertension in primary care: a cluster randomised controlled trial
by: Birsen Kiliç, et al.
Published: (2025-07-01)

Arterial hypertension and stroke primary prevention
by: O. D. Ostroumova, et al.
Published: (2005-08-01)

Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study)
by: Yu. A. Balanova, et al.
Published: (2019-09-01)

Malnutrition and Muscle Loss Mediate the Association Between NT-proBNP and Mortality in Hospitalized Older Adults
by: Tao J, et al.
Published: (2025-08-01)